Shanghai - Delayed Quote CNY

Ginwa Enterprise (Group) Inc. (600080.SS)

6.69 -0.02 (-0.30%)
At close: April 19 at 3:00 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Ms. Yajuan Ju Financial Director -- -- 1981
Mr. Boyue Xing Deputy GM & Director -- -- 1996
Mr. Ming Sun Board Secretary -- -- 1972

Ginwa Enterprise (Group) Inc.

No. 202, Keji 4th Road
High-tech Zone
Xi'an
China
86 29 8220 0221 https://www.ginwa.com.cn
Sector: 
Healthcare
Full Time Employees: 
600

Description

Ginwa Enterprise (Group) Inc. researches, develops, produces, and sells pharmaceuticals in China. The company offers orthopedic, immune, pediatric, antibiotic, digestive system, gynecological, cardiovascular, antipyretic, analgesic, antiviral, and other products. It offers its products in the form of tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. In addition, the company provides chemical drugs, Chinese medicines, raw materials, and health related products. Ginwa Enterprise (Group) Inc. was founded in 1996 and is based in Xi'an, China.

Corporate Governance

Ginwa Enterprise (Group) Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Jun 17, 2021
    Ex-Dividend Date

Upcoming Events